The prognosis of patients with ccRCC has improved remarkably due to more advanced diagnosis and treatment methods such as the Da Vinci surgical system 33 and anti-VEGF or VEGFR therapy 34, 35. The gene discussed is VEGFA; the disease is nonpapillary renal cell carcinoma.